ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0885

Reproducible Single Cell Annotation of Programs Underlying T-cell Subsets, Activation States, and Functions

Dylan Kotliar1, Michelle Curtis1, Ryan Agnew1, Kathryn Weinand1, Aparna Nathan2, Yuriy Baglaenko1, Yu Zhao1, Pardis Sabeti3, Deepak Rao4 and Soumya Raychaudhuri1, 1Brigham and Women's Hospital, Boston, MA, 2Harvard Medical School, Boston, MA, 3Broad Institute, Boston, MA, 4Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Meeting: ACR Convergence 2024

Keywords: Gene Expression, genomics, Statistical methods, T Cell, TH17 Cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Genetics, Genomics & Proteomics Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: T-cells play a key role in the pathogenesis of autoimmune disease and in protection against cancer and infection. Consequently, there is widespread interest in characterizing T-cell states in disease tissue using single-cell RNA sequencing (scRNA-Seq). However, such data has proven challenging to interpret. scRNA-Seq has revealed a continuum of T-cell states without discrete clusters corresponding to expected subsets (e.g. Th1, Th2, and Th17). Furthermore, it is unclear how to identify T-cells that have recently been activated by antigen. Understanding the subset and activation status of T-cells in disease tissue can shed light on pathogenesis.

Methods: We developed T-CellAnnoTator (TCAT), a computational pipeline that overcomes these limitations of T-cell scRNA-Seq analysis. TCAT analyzes multiple reference datasets to derive a catalog of gene expression programs (GEPs) capturing the core functions of T-cells (e.g. polarization states, cytotoxicity, and exhaustion). It then infers the activity of these programs in new query datasets, enabling users to annotate subsets, antigen-specific activation status, and other GEPs in their data.

Results: We discovered 46 reproducible GEPs from 1,700,000 T-cells from 700 individuals across 38 tissues and five diverse disease contexts. These GEPs capture all known major T-cell subsets and several known and novel antigen-specific activation responses. We show that TCAT predicts T-cell subsets in silico and in vivo with high accuracy. We identify associations of GEPs with disease states and highlight the enrichment of T peripheral helper (Tph) cells in tumors and Covid-19. We show widespread Th2-polarized CD8 T-cells in peripheral blood. We also document wide variability in the percentage of activated, exhausted, and proliferating T-cells in Rheumatoid Arthritis synovia and in tumors.

Conclusion: Our software enables users to easily annotate single-cell profiles of T-cells with subsets and activation-state information, providing insight into which T-cell are being activated by antigens and which are “bystanders” within disease tissue. The overall strategy can be generalized to all cell types and tissues. We make TCAT publicly available and have created a repository to host GEP catalogs from new tissues, enabling easy application to new datasets.

Supporting image 1

Figure 1. (A) Schematic of the T-CellAnnoTator (TCAT) pipeline. (B) Three example TCAT outputs in a dataset of rheumatoid arthritis synovial T-cells. Cells are colored based on their usage of the specified feature on a Uniform Manifold Approximation and Projection (UMAP) embedding.

Disclosures: D. Kotliar: None; M. Curtis: None; R. Agnew: None; K. Weinand: None; A. Nathan: None; Y. Baglaenko: None; Y. Zhao: None; P. Sabeti: Danaher Corporation, 11, Delve Bio, 2, 4, 11, Sherlock Biosciences, 2, 4, 11; D. Rao: Amgen, 6, AnaptysBio, 2, AstraZeneca, 1, Bristol-Myers Squibb, 2, 5, GlaxoSmithKline, 2, HiFiBio, 2, Janssen, 5, Merck, 5, Scipher Medicine, 2; S. Raychaudhuri: Janssen, 1, Mestag, 8, Nimbus, 2, Pfizer, 1, Sonoma, 8, Third Rock Ventures, 2.

To cite this abstract in AMA style:

Kotliar D, Curtis M, Agnew R, Weinand K, Nathan A, Baglaenko Y, Zhao Y, Sabeti P, Rao D, Raychaudhuri S. Reproducible Single Cell Annotation of Programs Underlying T-cell Subsets, Activation States, and Functions [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/reproducible-single-cell-annotation-of-programs-underlying-t-cell-subsets-activation-states-and-functions/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/reproducible-single-cell-annotation-of-programs-underlying-t-cell-subsets-activation-states-and-functions/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology